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Summary We have employed molecular probes produced from DNA fragments of human papillomavirus,
cloned into prokaryotic vectors, to detect virus nucleic acid sequences in extracts of human oral tissues. The
study was conducted with duplicate coded snap-frozen tissue biopsies from which frozen sections had been
taken to accurately assess the pathology of each particular sample.
The results show that a large proportion of the oral biopsies contained DNA which hybridized to the viral
DNA probes, even under conditions of high stringency. The presence of virus did not correlate with neoplasia
in the tissues examined, but HPV like sequences were found in a high proportion (80%) of biopsies taken
from areas of keratosis and lichen planus and also in 41 to 46% of normal and tumour tissues.
Human oral cancer is a major source of mortality in the
third world, accounting for 40-50% of all malignancies in
some areas of India and SE Asia (Pindborg, 1984). The
tumour is relatively uncommon in the United Kingdom,
constituting 2-3% of all malignancies, with the incidence
showing marked regional variations (Binnie et al., 1972), and
sero-epidemiological studies infer the involvement of an
unknown infectious agent in the aetiology of the disease
(reviewed by Scully et al., 1985). The latter features have
prompted considerable research efforts designed to detect the
presence of human viruses in oral carcinoma biopsies (Eglin
et al., 1983; de Villiers et al., 1985). Initial results, using both
antisera against herpes simplex virus (HSV) proteins
(Shillitoe et al., 1976) and HSV specific gene probes (Eglin et
al., 1983) indicated a possible aetiological role for this virus,
as was also postulated for HSV and human cervical
carcinoma (Nahmias et al., 1974). In view of more recent
evidence of cross-hybridization between HSV DNA and
normal human cell nucleic acids (Maitland et al., 1981;
Peden et al., 1983) and the extremely high prevalence of
HSV in the general population, an aetiological relationship
between HSV and both oral and cervical carcinoma is now
considered to be less likely, although it cannot be excluded
entirely.
We wished to define more carefully the role which human
papillomavirus (HPV) plays in oral disease and oral
squamous cell carcinoma in particular. The association of
oral carcinomas and other oral mucosal lesions has been
recognised for many years. Often these lesions present as
'white plaques' leukoplakia), 3-6% of which convert to
malignancy (Henk & Langdon, 1985). The commonest cause
of oral leukoplakia is simple hyperkeratosis, as induced by
trauma or friction. However in cases where no such trauma
is observed, the lesion is normally termed 'non-specific
keratosis'. The potential of the latter lesions to undergo
malignant conversion is dependent on the degree of histo-
logical epithelial dysplasia. A further type of reticular oral
leukoplakia, but where the relationship with oral cancer is
more controversial, is oral lichen planus, the aetiology of
which is presently unknown. A number of studies have
reported the detection of HPV genes and antigens in both
oral papillary lesions (Loning et al., 1985) and in biopsies of
hyperplastic and carcinoma tissues (de Villiers et al., 1986),
but in general patient numbers have been small and the
studies have been largely uncontrolled, employing only small
numbers of normal or non-malignant tissue biopsies.
The oncogenic potential of papillomaviruses has been
clearly demonstrated both in vivo (Jarrett et al., 1978) and in
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vitro (Moar et al., 1981; Campo & Spandidos, 1983) for
bovine papillomaviruses (e.g. BPV4), although the situation
with HPV is less clear (Burnett & Gallimore, 1983;
Yasumoto et al., 1986). It has been suggested that the type
of HPV (e.g. HPV types 16, 18 and 31 in cervical carcinoma)
is important in the aetiology of the cancer (zur Hausen,
1977; Boshart et al., 1984; Pfister, 1984), and that the
intracellular state of the viral genome changes between
premalignant and malignant tissues viz. from free episomal
copies in the benign lesions, to at least partly integrated into
the cell chromosome in the malignancies (Schwarz et al.,
1985; Yee et al., 1985). It does appear, however, that high
level expression of the viral genes is not obligatory in
carcinoma cells (Lehn et al., 1985; Yee et al., 1985), which
may infer an initiator, rather than a maintenance role for
HPV as a carcinogen. The latter information has been
obtained from the study of cervical carcinoma tissue,
samples of which were available to us for use as positive
controls in parallel with our oral tissues.
With the increasing availability of cloned gene probes for
human papillomaviruses (Heilman et al., 1980), and the
frequent detection of particularly types 16, 18 and 31 in
almost 80% of human cervical biopsies, considerable interest
(Loning et al., 1985; de Villiers et al., 1986) has been
focussed on whether these viruses, or a closely related type,
are present in oral carcinoma, given the similar nature of the
oral and cervical epithelium. In this study, we have employed
a molecularly cloned HPV16 genome (obtained from Prof H.
zur Hausen, Heidelberg, FRG) as a probe for the analysis of
DNA from 48 coded biopsies of human oral tissue, of
normal, non-malignant and tumour origin. The results
indicate that, whereas HPV is present in a high proportion
of keratinising non-malignant lesions, and also in normal
and carcinoma biopsies, there is no significant association of
HPV with the carcinoma.
Materials and methods
Biopsies were obtained of normal human oral tissue taken
from the buccal mucosa of individuals with no clinical
history or evidence of papillomavirus infection, and normal
cervical mucosa (see Cox et al., 1986). Premalignant oral
lesion (keratosis) and oral lichen planus biopsies were also
taken from buccal mucosa. All the oral squamous cell
carcinoma biopsies were taken from the lateral border of the
tongue and the floor of the mouth, and were classified as
well differentiated by haematoxylin and eosin staining.
Cervical carcinoma biopsies were taken from tumours classi-
fied as invasive squamous cell carcinomas and adeno-
carcinoma (Meanwell et al., 1987). Oral biopsies were
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obtained from the University department of Oral Medicine
and Oral Surgery, Bristol. Cervical biopsies were supplied by
the West Midlands CRC Clinical trials Unit, Birmingham
University.
Upon excision, biopsy specimens were immediately snap
frozen in liquid nitrogen and stored at -70°C until use.
Routine histological examination of tissues was carried out
by haematoxylin and eosin staining.
High molecular weight DNA and RNA were extracted
from the frozen tissues by a modification of the method of
Chirgwin et al. (1979). In brief, tissues were homogenised in
4M guanadinium thiocyanate and transferred to a two-step
caesium trifluroacetate density gradient (Pharmacia) for
centrifugation overnight at 40,000rpm, 18°C in a Sorvall
AH650 rotor. RNA and DNA were then harvested. The
DNA was repeatedly phenol/chloroform extracted until all
traces of cellular protein had been removed. The final
supernatant was concentrated by addition of 1/10th volume
3M sodium acetate and 2 volumes of ethanol. The DNA
precipitate was ethanol washed, dried and redissolved in
10mM Tris HCI, 1 mM ethylene diamine tetraacetic acid
(EDTA) pH 8.0 to a concentration of 1 pg per 2pl.
Restriction endonuclease digestion andgel electrophoresis
Ten micrograms of cellular DNA or 2 pg cloned DNA were
digested with 10-20 units of appropriate restriction endo-
nuclease (Pharmacia or Bethesda Research Laboratories).
Cellular DNA was digested for 24h at 37°C in the presence
of 1/10 volume ribonuclease A (200pgml-1), 1/20 volume
gelatin (2mgml-1), and 1/20 volume spermidine (80mM).
DNA was then electrophoresed in 0.8%-1.0% agarose gels
(Sigma) using Tris (hydroxymethyl) aminomethane (TRIS)
0.04M, sodium acetate 0.005M and EDTA 0.001M, pH7.9
as running buffer and transferred to Hybond-N filters
(Amersham) according to the manufacturer's protocol.
HPV-reconstructions
To gain an estimate of the sensitivity of our hybridization
techniques and the number of copies of HPV-16 per cell,
HPV16 reconstructions were made. Known amounts of
HPV16 DNA (2x 10-3pg, 2x 10-4 jug and 2x10-5pg,
corresponding to 100, 10 and 1 genomes recpectively), were
mixed with 10 pg HPV-negative human DNA, restriction
endonuclease digested, co-electrophoresed, and blotted to act
as standards. The detection level was less than 1 copy of
HPV16 DNA per cell. Quantification of HPV copy number
in the reconstruction and biopsy tracks was made by using a
Bio-Rad Video Densitometer, model 620.
Probe preparation
HPV type 16 cloned into the Bam HI site of pBR322 was a
kind gift from Prof H. zur Hausen (Heidelberg, Germany).
Following Bam HI digestion and low melting point agarose
purification, 10-50 ng of HPV16 insert was oligo-labelled
Feinberg and Vogelstein (1983), using 32P labelled dCTP
(Amersham) to a specific activity of -1 x 109 cpm pg- 1.
Hybridization
Filters were prehybridized in 2 x SSC (1 x SSC =0.15 M
NaCl, 0.015M sodium citrate pH 7.0), 10% dextran sulphate,
10 x Denhardt's solution (0.2% Bovine serum albumin, 0.2%
ficoll, 0.2% polyvinyl pyrrolidone) (Denhardt, 1966), 0.5%
sodium dodecyl sulphate (SDS), 2mM EDTA, denatured
salmon sperm (100Ipgml-1) and 33% formamide at 45°C,
for a minimum of 4h.
The 32P-labelled HPV16 probe was heat denatured by
boiling for 10 min and added to the prehybridization
solution at a concentration of 106 cpm ml-. Hybridization
was performed for 18h in plastic bags at 45°C using 100pl
of the solution for each cm2 of filter.
Following hybridization, the filters were washed at
moderate stringency (Tm-22°C): in 2 x SSC at room tempera-
ture for 30min, twice in 2 x SSC plus 0.5% SDS at 65°C for
2h and finally in 0.1% SSC at room temperature for 30min.
Filters were exposed to Fuji X-ray film for up to 72h with
an intensifying screen and then washed at high stringency
(Tm-9°C): twice in 0.1 xSSC plus 0.5% SDS for 2h at
65°C and re-exposed for 72-120 h.
Probe removal and re-use ofDNA blots.
Probes were removed by incubating nylon membranes at
45°C for 30min in 0.4 M sodium hydroxide, followed by
incubation in 0.1 x SCC, 0.1% (w/v) SDS, and 0.2M tris-
HCI, pH 7.5 for 30min at 45°C. Filters were then treated as
above.
Results
DNA hybridizations with oral biopsies
In most cases the amounts of DNA extracted from the oral
biopsies were only sufficient to perform 1 or 2 digestions and
therefore the typing of any virus detected was necessarily less
complete than with control cervical biopsies, which were
analysed in parallel. The lower yields of nucleic acid from
the oral tissues were not due to the generally smaller biopsies
or a different biopsy procedure, but may simply reflect the
high levels of degradative enzymes in the oral cavity,
compared to the cervix.
Where possible the DNA samples were digested with 4
restriction endonucleases viz. BamHI, Dra I, HindIII and
Pst I. The different cleavage patterns produced by these
enzymes with different HPV genotypes permitted rapid
identification of the viral DNA present in each tumour
biopsy. In addition, the stringency of our hybridization
conditions was sufficient to differentiate between HPV type
16 and types 1, 2, 4, 6, 11, 13 and 18. Although the
hybridization probe used in all the experiments described
below was HPV16, the presence of other HPV types was
tested in the course of the study by employing both mixed
probes, containing the HPV types listed above and less
stringent hybridization conditions (data not shown). In an
attempt to quantify the HPV DNA content of the oral
tissues a series of reconstruction tracks (consisting of
measured amounts of HPV16 DNA added to HPV-negative
human DNA - see Materials and methods) were included in
each hybridization. This strategy also allowed us to
standardise detection levels between different experiments,
where a weak signal in the presence of a number of strong
signals could often be missed.
To ensure complete objectivity, in all cases the pathology
of the biopsies was not known until the hybridization
experiments had been completed. The results of these hybrid-
izations, which were performed up to 4 times for each
biopsy , are summarised in Table I.
Table I Detection of human papilloma virus
DNA in human oral tissuea









aTotal number of biopsies=48; bPercentage of
oral tissues positive for HPV=60% (28/48).HPV TYPE 16 IN HUMAN ORAL TISSUES
The most striking feature of these results was the high
proportion of premalignant and benign oral lesions, for
example almost all degrees of keratosis tested (9/11), which
contained papillomavirus DNA. In addition, lichen planus, a
reticular form of keratosis, which was thought to have an
immunological aetiology, also contained HPV in the
majority of cases (7/8). It may be significant that these
lesions manifest themselves clinically as 'white patches',
similar to those found to contain HPV in the cervix (Henk &
Langdon, 1985).
In contrast, the proportions of both histologically normal
and carcinoma biopsies which contained HPV DNA were
virtually identical (5/12 and 7/15 respectively). The carci-
noma biopsies covered the complete range of differentiated
types from poorly to well differentiated on the basis of
haematoxylin/eosin staining, although the majority were well
differentiated. There was no significant association of HPV
DNA detection with the differentiated state of the tumour.
The negative results obtained with the severe dysplasia and
the verrucous hyperplasia biopsies were not significant in
view of the single biopsies of each type assayed.
In all the oral biopsies except two (see below) the type of
virus detected was either a variant of HPV16 which we have
detected in two positive cervical biopsies, or the prototype
HPV16 as detected in cervical controls (Meanwell et al.,
1987), since (i) HPV was detected under hybridization con-
ditions of high stringency and (ii) the Dra I pattern was
identical to that of HPV16. In more than 95% of oral
biopsies, the variant HPV16 was the principal type detected,
although for 5 of the oral biopsies only the DraI digestion
results were interpretable, and a PstI digest pattern is
required to distinguish prototype from variant. Representa-
tive digestion patterns for the oral tissue DNA, digested with
either PstI or DraI are shown in Figures 1 and 2 respec-
tively. The slightly different mobilities in some of the tracks
are due to differing electrophoretic conditions. Bands from
different experiments were aligned by reference to bacterio-
phage lambda molecular weight markers, and the internal







Figure 2 Detection of HPV DNA in human tissue biopsies. Ten
pg samples of Dra I digested DNA from tissue extracts were
immobilised on Hybond-N filters and hybridized with an HPV
16 DNA probe. Lane a is a cervical normal tissue, lane b is a
normal oral tissue, lane c is an oral lichen planus lesion and lane
c is an oral squamous cell carcinoma. The positions of character-
istic Dra I HPV 16 fragments are arrowed on the left of the
figure. Open arrowheads indicate unique HPV sequences, while
the asterisks represent putative virus-cell junction fragments.
One carcinoma (Figure 1 lane i), and one lichen planus
lesion (Figure 2, lane c), appeared to harbour HPV-related
sequences which did not correspond to either of the two
HPV16 types detected. These sequences hybridized extremely
poorly, even under moderately stringent conditions, and
their restriction patterns did not correspond to any of our
panel of likely HPV's (1, 2, 4, 6, 11, 13, 18) when cleaved
with either DraI or PstI. Rehybridization of the filters with
a mixed probe containing all the different HPV types
including HPV16 did not intensify the hybridization signals
i i k
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Figure 1 Detection of HPV 16 DNA and HPV 16 related sequences in human tissue biopsies. Ten pg sampls ofPst I digested tissue
extracts were immobilised on Hybond-N filters and hybridized with an HPV 16 probe. Lanes d, h, and k are cervical squamous
cell carcinomas, lanes b, f and g are normal oral tissues, lanes e and i are oral squamous cell carcinomas, lane a is an oral lichen
planus lesion, lane c is an oral non-specific keratosis, lane j is a normal cervical tissue. The HPV 16 Pst I fragments are indicated
by arrows and capitals, while open arrowheads represent unique HPV sequences (see text). The missing Pst I 'C' fragment in lane
k is bracketed to allow comparison of molecular weights between the 3 different experiments.248 N.J. MAITLAND et al.
(data not shown). We therefore conclude that these two oral
lesions contain novel genotypes of HPV.
Copy numbers and state of the HPV DNA in the tissue
extracts
By comparison with the reconstructions a wide variability in
the number of copies of the HPV genome/diploid cell was
observed in both oral and cervical tissue biopsies. All HPV
positive oral biopsies contained between 1 and 100 HPV
copies per diploid cell, with only one oral biopsy containing
as many as 200 copies. In contrast, the cervical control
biopsies showed slightly higher HPV copy numbers, in the
range 1-250 copies per cell.
By careful examination of the southern blot it is possible
to determine whether the HPV DNA exists as monomeric or
oligomeric episomes, or as monomers or concatamers of
virus DNA integrated into the human chromosome. Since
integrated virus will produce restriction endonuclease
fragments consisting of both cell and HPV DNA, 'junction
fragments' of this type will show altered mobility, compared
to purely viral fragments. In biopsies containing an average
of more than one HPV copy/cell, junction fragments of this
type are normally present at lower concentrations than the
purely viral fragments (indicating multiple copies of the virus
DNA integrated at a few chromosomal sites) and are
normally variable in molecular weight in tissue extracts from
different patients. Alternatively, 'junction' fragments could
also indicate rearrangement of or recombination within the
viral genome. We examined both PstI and DraI digests for
such fragments of unusual molecular weight. We have
previously observed this type of evidence for integration in
some cervical carcinoma but not in normal tissue biopsies
(Meanwell et al., 1987). However, only one oral biopsy
contained evidence of integration, a normal tissue biopsy,
indicated in Figure 2 (lane b) by asterisks. High molecular
weight bands were observed in a further biopsy (Figure 2,
lane d) but in this case the pattern was too complex to
exclude the possibility of partial digestion of the DNA.
This was in spite of the use of a 4-fold excess of endo-
nuclease for up to 24h at 37°C, which achieved complete
digestion of almost every DNA sample. The completeness, of
digestion was also monitored by observation of 'satellite'
bands on the agarose gel and by hybridization of the filters
with cellular gene probes (data not shown). Thus we
conclude that the HPV genomes are rarely, if ever, integrated
in human oral tissues.
Discussion
The aim of this study was to determine the role, if any,
played by human papillomaviruses in oral disease, with
specific reference to oral squamous cell carcinoma. As
controls for the detection of HPV in these experiments we
were supplied with normal and neoplastic human cervical
tissues. It is now accepted that HPV types 16 and 18 are
present in a high proportion of cervical carcinoma biopsies
(Durst et al., 1983; Schwarz et al., 1985; Yee et al., 1985). To
ensure objectivity the patients from whom both the cervical
and oral biopsies were taken, were number coded at source
and were tested using duplicate biopsies where possible.
Normal tissues biopsies were taken from patients with
neither clinical nor histological evidence of disease.
To our surprise, normal tissue from patients with no
evidence of papillomas or cancer, were clearly positive for
either the prototype HPV16 or a putative subtype of this
virus. The variant subtype had an apparent molecular size of
6.8 kilo-base pairs (kbp) compared to that of 7.9kbp for
prototype HPV16, since, upon Pst I digestion it appeared to
lack the Pst I 'C' fragment. Interestingly, de Villiers et al.
(1985) have recently detected a papillomavirus with the same
PstI digestion pattern in a human tongue carcinoma. This
variant virus, which was the major type present in all oral
biopsies, was also detected in two cervical carcinoma
biopsies. Perhaps the situation is similar to that found with
herpex simplex virus where regional variations in the pro-
portions of the oral type (HSV1) and the genital variant
(HSV2) in the general population are quite frequent (Smith
et al., 1981).
Almost 46% of the oral carcinoma biopsies tested, and
approximately the same proportion of normal biopsies (41%)
were positive for variant HPV16. This value was in close
agreement with our results employing human cervical tissue
DNA (Cox et al., 1986; Meanwell et al., 1987), where 33%
of normal cervical biopsies contained HPV16, although the
proportion of cervical carcinoma biopsies which were HPV16
positive was considerably greater (66%). Both of the non-
malignant oral lesions examined (lichen planus and various
degrees of keratosis) were far more frequently positive for
HPV (87% and 82% respectively). This result clearly
suggests a viral aetiology for the latter lesions. In addition,
two oral biopsies appeared to harbour other HPV related
sequences as indicated in Figures 1 and 2 by open arrow-
heads. The PstI and DraI digestion patterns in these two
cases did not correspond to any prototype HPV to which we
have access, and the DNA sequences only hybridized to the
HPV16 probe with reduced efficiency. Therefore other, as yet
untyped HPVs may play a role in oral disease.
The regular and frequent detection of HPV16 related
sequences in biopsies of normal tissue is the major difference
between our results and most published work, which
suggests that fewer than 10% of the normal population carry
HPV16. We believe that this discrepancy may be due to
different biopsy procedures. Most other studies have
employed either statistically insignificant numbers of normal,
as compared to tumour samples, or have taken selective
normal biopsies from cancer patients. In large scale surveys,
the usual method of sampling has been to scrape or brush
off the outer layers of the epithelium (Schneider et al., 1985).
In all the normal cases reported in this paper full depth
epithelial biopsies, including the basal layers, were taken,
and verified by histological analysis of frozen sections
adjacent to the extracted tissue fragment. Since it is generally
assumed (Pfister, 1984) that the target cell for HPV infection
is in the basal layer of the epithelium (although no rigorous
proof is as yet available), by adopting this procedure we
expected to detect both latent and replicating virus, instead
of simply the replicating virus to be found in the superficial
layers. Therefore all surveys, based on brush sampling, will
not measure the true incidence of HPV16, but rather the
incidence of productive infection in the general population.
The presence of low intensity bands on a large number of
HPV hybridizations to Pst I digests of human DNA has been
interpreted as being indicative of integration of the HPV into
the cellular chromosome (McCance et al., 1986; Choo et al.,
1987), although faint bands of identical molecular weight
were observed in samples from different patients. This result
would infer probable integration of HPV at the same or very
similar chromosomal locations. It is almost unknown for
exactly the same integration site to occur in different indi-
viduals after transformation by a DNA tumour virus, even
with inbred laboratory animals. Bands of similar molecular
weight were observed in our earliest experiments, which
employed nick-translated HPV16 +pBR322 vector as the
probe and were subsequently shown to derive from hybrid-
ization between the pBR322 and a contaminant in the
commercially produced restriction endonuclease preparation
(data not shown). Similar contaminations have resulted in
misinterpretation of other results (Firnhaber et al., 1986).
We would suggest, on the basis of our results that in both
cervix (Meanwell et al., 1987) and oral tissue biopsies that
integration is rarer than at first suspected and that the only
true demonstration of viral integration is either by probing
the limited amounts of DNA available from tissue biopsies
with individual sub-genomic fragments of HPV16 or by
cloning out the cell-virus junction fragments.HPV TYPE 16 IN HUMAN ORAL TISSUES 249
One deficiency in the analysis of viral genes in tumour
biopsies is their retrospective nature. To prove an aetio-
logical relationship, it would be necessary to follow the
natural history of disease in normal patients, with and
without HPV16. Such a study will be both ethically and
practically difficult since the taking of the full depth epi-
thelial biopsies, which this work suggests are essential, could
in fact predispose to development of epithelial abnormalities.
A second problem with detection of virus in extracts of
tissue biopsies is that any measurement of 'copy number' for
HPV is an average over all the cell types present in the
biopsy i.e. tumour cells, connective tissue and infiltrating
leucocytes. Depending on the tumour cell content of
biopsies, the actual copy number of HPV in the tumour cells
may be as high as 2,000 per cell. Such copy numbers are
more indicative of productive viral infection than transfor-
mation. In addition, there is no certainty that each tumour
cell contains an equivalent amount of the HPV DNA. The
only way to resolve this question is to perform in situ
hybridizations on to frozen sections of tissue. Our results on
cervical tissue (submitted) suggest that the distribution of
HPV DNA in cervical tumours is nodal within the tumour
cells and may correlate with the differentiated state of the
cells, as determined by immunocytochemistry but not by
standard haematoxylin and eosin stain. This may also be
indicative of differentiation related viral genome replication.
Preliminary studies on oral tissue also indicate a nodal
distribution for HPV DNA in tumour and normal tissue.
Our results exclude the possibility that HPV is the single
aetiological agent responsible for human oral cancer, since it
was detected in a high proportion of normal, non-malignant
and pre-malignant disease samples. Detection of HPV DNA
alone is therefore a poor prognostic indicator for the
individuals who are at risk of developing oral cancer. Were
the virus to play a role in human oral cancer, it is more
likely to act as an initiator of proliferation, since we find
HPV in a large percentage of pre-maligant and non-
malignant proliferative disease samples. At present we have
no evidence whether the presence of HPV correlates with
degree of malignancy in oral tumours although our own data
from cervical studies do not favour this association
(Meanwell et al., 1987). We also have preliminary evidence
to suggest that HPV is not expressed as mRNA in all
biopsies, including those containing large numbers of viral
genomes. This result would also argue against an active role
for the virus as a source of 'tumour antigen'. Similar work
on cervical tumours indicated that HPV was not transcribed
in all the HPV positive tumour tested (Lehn et al., 1985; Yee
et al., 1985). Therefore considerable further study is required
before the precise role, if any, which is played by HPV in the
induction of human oral cancer can be defined.
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